Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

95.55 -3.91 (-3.94%)
Streaming Delayed Price Updated: 10:06 AM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novartis Ag ADR

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
CureVac BV (NASDAQ: CVAC) has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners. The Company would... 
Via Benzinga
Exposures COVID-19
Why Regenxbio Stock Is Way Up Today
American biopharmaceutical giant AbbVie wants access to Regenexbio's gene therapy for macular degeneration. 
Via The Motley Fool
ADHD Drug Developer Cingulate Plans NASDAQ Debut
Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
What may be behind achy, tired, or burning eyes? Dry eye disease may be the culprit.
(BPT) - Sponsored by Novartis Pharmaceuticals Corporation. 
Via Brandpoint
Exposures COVID-19
Why Did Wedbush Downgrade Xoma?
Wedbush has cut XOMA Corporation (NASDAQ: XOMA) to neutral from outperform and lowered its price target to $22 from $41. Analyst Liana Moussatos notes ... 
Via Benzinga
Understanding Novartis's Unusual Options Activity
Novartis (NYSE:NVS) shares experienced unusual options activ... 
Via Benzinga
Novartis Stops Iscalimab Trial In Kidney Transplant Patients
Novartis AG (NYSE: NVS) has halted a Phase 2 trial of CFZ533 (iscalimab) in kidney transplant patients. The decision follows interim data that showed iscalimab was... 
Via Benzinga
Price Over Earnings Overview: Novartis
Looking into the current session, Novartis Inc. (NYSE:NVS) is trading at $92.23, after a 0.45% drop. Over the past month, the stock decreased by 0.02%, but over the... 
Via Benzinga
The Rising Delta Variant
China is not only cracking down on kiddie playtime. It also is absorbing bankruptcy claims from real estate developer Evergrande. 
Via Talk Markets
Topics Bankruptcy
Exposures Financial Legal
Novartis, NHS England Ink Access Deal For Cholesterol Drug Leqvio
The U.K. government, NHS England, and Novartis AG (NYSE: NVS) unveiled a "world-first" reimbursement deal for providing broader access to anti-cholesterol... 
Via Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
The European Commission has cleared UCB's (OTC: UCBJF) Bimzelx (bimekizumab) for moderate to severe plaque psoriasis in adults. UCB's confidence lies in... 
Via Benzinga
Living with Chronic Hives: One Woman’s Story
(BPT) - Ilana, a board-certified emergency medicine physician, lived with chronic hives for almost as long as she can remember. 'I've had them since I was at least 8 years old,' she says. 'It's... 
Via Brandpoint
Exposures Product Safety
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Exposures COVID-19
Novartis' STAMP Inhibitor Under FDA Review For Myeloid Leukemia
The FDA has accepted for review Novartis AG's (NYSE: NVS) marketing application seeking approval for asciminib (ABL001) in chronic myeloid leukemia (CML).... 
Via Benzinga
Exposures Product Safety
Only The Conservative Pot Stocks Index Is Up YTD And Currently Yields 4.9%
If you were to invest in a basket of the major companies that have bought into marijuana companies you could possibly generate greater returns than only owning the associated marijuana company. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Exposures Product Safety
Novartis's Kymriah Flunks In Late-Stage NHL Study
Novartis AG's (NYSE: NVS) Kymriah (tisagenlecleucel) CAR-T therapy failed to meet its primary endpoint of event-free survival in a Phase 3 study in aggressive... 
Via Benzinga
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the... 
Via Talk Markets
Exposures Product Safety
BEE Hits 10K Subscribers for BEE Pro, Company Poised to Accelerate Growth in H2
Companies such as Netflix, Harpercollins, Boston College, Novartis, Unicef, and Save the Children rely on BEE Pro to speed up & streamline email and landing page design. 
Via News Direct
Novartis Shares Two Year Beovu Data From Diabetic Macular Edema Studies
Novartis AG (NYSE: NVS) has reported data from two Phase 3 trials assessing Beovu (brolucizumab) 6 mg versus Regeneron Pharmaceuticals Inc's (NASDAQ: REGN... 
Via Benzinga
The Real World
The rise of the delta has caused markets to drop back after the rises earlier although inflation still remains within a point or two of forecasts at 5.3-5.4% annualized. 
Via Talk Markets
WHO-Led Study To Test Three Anti-Inflammatory Drugs For COVID-19
The World Health Organization (WHO) is set to start trials of three anti-inflammatory drugs to contain the spread of coronavirus to see if they can improve the... 
Via Benzinga
Exposures COVID-19
2 Dividend Stocks to Buy and Hold for Years
The stock market is experiencing substantial volatility due to concerns over high inflation and the worldwide spread of the COVID-19 Delta variant. 
Via Talk Markets
Exposures COVID-19
4 Steps You Can Take to Manage Heart Failure
(BPT) - Managing a chronic condition like heart failure (HF) can be challenging, especially as our society adapts to a new sense of normalcy. But with HF, management is crucial at all times. The good... 
Via Brandpoint
Exposures Product Safety
Markets: COVID Is Back
BP Plc reported earnings beats of 22 cents with a Q2 eps of 83 cents. Schlumberger Ltd, normally supported by French descendants from the founding Alsatian brothers, was hit by concern about the price... 
Via Talk Markets
Topics Earnings
Exposures Financial
3 Top Healthcare Stocks To Buy In August
The spread of the COVID-19 Delta variant has attracted attention to the healthcare industry. Since the industry is expected to grow in the coming months, we think it could be wise to bet on these... 
Via Talk Markets
Exposures COVID-19
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's Viola
BioHarvest Sciences Appoints Two Law Firms To Pursue Regulatory Approvals of Its Upcoming Cannabis and Hemp Products ... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Together Against Child Mortality: Novartis and Save the Children Launch Health Project in the Slums of Nairobi
Together Against Child Mortality: Novartis and Save the Children Launch Health Project in the Slums of Nairobi 
Via News Direct
Topics Death Intellectual Property
Exposures Death Intellectual Property
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.